Gateway Investment Advisers’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
RC
PIM
WHG
Gateway Investment Advisers's AVNS Position: Q2 2023 in Review
Gateway Investment Advisers sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 7,771 shares — an estimated $231K sold.
Gateway Investment Advisers first reported a position in AVNS in Q2 2016 and held it in 27 quarters. The position peaked at $926K in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.
- Gateway Investment Advisers reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
- Gateway Investment Advisers sold 7,771 Avanos Medical shares in Q2 2023, an estimated $231K.
- Gateway Investment Advisers first reported a position in Avanos Medical in Q2 2016 and held it in 27 quarters.
- Gateway Investment Advisers's Avanos Medical position peaked at $926K in Q3 2018.
- 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.
Based on Gateway Investment Advisers's 13F filing for Q2 2023, filed 14 Jul 2023.